Onegene Biotechnology

[Not Yet Scheduled]
Onegene Biotechnology is a biopharmaceutical company developing multi-targeting protein drugs for the treatment of non-alcoholic steatohepatitis (NASH), fibrotic diseases, and cancers. Our platform, UniStac®, allows simultaneous targeting of three or more targets, thereby potentially providing transformative opportunities to cure patients suffering from chronic and complex diseases.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
OGB21502
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2